There are 2789 resources available
423P - From clinical trial to bedside: Triplet chemotherapy (FOLFOXIRI-B) in metastatic colorectal cancer
Presenter: Guus Bol
Session: ePoster Display
405P - Prognostic value of neoadjuvant rectal score in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy
Presenter: Ana Carlota Caetano
Session: ePoster Display
406P - The analysis of driver mutations in paired samples of rectal carcinomas obtained before and after neoadjuvant chemoradiotherapy
Presenter: Evgeny Imyanitov
Session: ePoster Display
407P - Neoadjuvant chemo-radiotherapy response in patients affected by mismatch repair deficient (dMMR) locally advanced rectal cancer
Presenter: Andrea Pretta
Session: ePoster Display
408P - Characteristics of patients with colorectal cancer who underwent surgery for liver metastases and pattern of relapse
Presenter: Manuel Alva Bianchi
Session: ePoster Display
477P - Utilisation and predictors of genomic testing prior to first-line (1L) therapy in patients (pts) with metastatic colorectal cancer (mCRC)
Presenter: Heinz Josef Lenz
Session: ePoster Display
478P - TA-ness classification discriminates RAS wild-type (wt) metastatic colorectal cancer (mCRC) patients (pts) who may benefit from antiEGFR treatment
Presenter: Cristina Santos
Session: ePoster Display
479P - Difference gene mutations among CRC patients with MSS and MSI-H types in China
Presenter: Jianjun Yang
Session: ePoster Display
480P - Gene expression of NANOG and NANOGP8 in colorectal cancer
Presenter: Hiroyuki Arai
Session: ePoster Display
481P - Evaluation of serum mid-infrared spectroscopy as new prognostic marker for bevacizumab-based chemotherapy in first-line treatment of metastatic colorectal cancer
Presenter: Romain Chautard
Session: ePoster Display